PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2009 | 59 | 3 |

Tytuł artykułu

Growth hormone and insulin-like growth factor -1 axis response to low protein diet in chronic kidney disease- a short report

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The aim of this study was to asses the influence of a conventional low-protein diet and diet supplemented with Ketosteril® on growth hormone and insulin-like growth factor-1 in patients with chronic kidney disease (CKD). Dietary intake of selected nutrients, anthropometric, hormonal and metabolic parameters were analysed before and after 6-month dietary treatment. We conclude that in CKD the response of the GH and IGF-I axis to a low protein diet can be determined by the quality of proteins and that animal protein seems to promote an increase in GH.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

59

Numer

3

Opis fizyczny

p.279-282,ref.

Twórcy

  • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw Agricultural University, ul. Nowoursynowska 159C, 02-796, Warsaw, Poland
autor
  • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw Agricultural University, ul. Nowoursynowska 159C, 02-796, Warsaw, Poland
autor
  • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw Agricultural University, ul. Nowoursynowska 159C, 02-796, Warsaw, Poland
autor
  • Department of Internal Medicine and Nephrology, MSS, Warsaw
  • Department of Internal Medicine and Nephrology, CSK MSWiA, Warsaw
autor
  • Department of Internal Medicine and Nephrology, CSK MSWiA, Warsaw
  • Institute of Experimental and Clinical Medicine, Polish Academy of Sciences, Warsaw, Poland

Bibliografia

  • 1. Garibotto G., Barreca A., Russo R., Sofia A., Araghi P., Cesarone A., Malaspina M., Fiorini F., Minuto F., Tizianello A., Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J. Clin. Invest., 1997, 99, 97–105.
  • 2. Giordano R., Bonelli L., Marinazzo E., Ghigo E., Arvat E., Growth hormone treatment in human ageing: benefits and risks. Hormones (Athens), 2008, 7, 133–139.
  • 3. Haffner D., Schaefer F., Girard J., Ritz E., Mehls O., Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J. Clin. Invest., 1994, 93, 1163–71.
  • 4. Ikizler T.A., Wingard R.L., Flakoll P.J., Schulman G., Parker R.A., Hakim R.M., Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients. Kidney Int., 1996, 50, 229–234.
  • 5. Kaskel F.E., Chronic renal disease: A growing problem. Kidney Int., 2003, 64, 1141–1151.
  • 6. Levey A.S., Bosch J.P., Lewis J.B., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 1999, 130, 461–470.
  • 7. Mak R.H., Cheung W.W., Roberts C.T. Jr., The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth. Horm. IGF Res., 2008, 18, 17–25.
  • 8. Muller E.E., Locatelli V., Cocchi D., Neuroendocrine control of growth hormone secretion. Physiol. Rev., 1999, 79, 511–607.
  • 9. Thissen J.P., Ketelslegers J.M., Underwood L.E., Nutritional regulation of the insulin-like growth factors. Endocr. Rev., 1994, 15, 80–101.
  • 10. Zadik Z., Frishberg Y., Drukker A., Blachar Y., Lotan D., Levi S., Reifeh R., Excessive dietary protein and suboptimal caloric intake have a negative effect on the growth of the children with chronic renal disease before and during growth hormone therapy. Metabolism, 1998, 47, 264–268.

Uwagi

rekord w opracowaniu

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-ddec675e-a035-450d-bb54-42de7bfe4da2
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.